Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in PLoS Biol

Retrieve available abstracts of 82 articles:
HTML format

Single Articles

    March 2024
  1. BEKDASH R, Yoshida K, Nair MS, Qiu L, et al
    Developing inhibitory peptides against SARS-CoV-2 envelope protein.
    PLoS Biol. 2024;22:e3002522.
    PubMed     Abstract available

    January 2024
  2. RUSSELL TW, Townsley H, Abbott S, Hellewell J, et al
    Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.
    PLoS Biol. 2024;22:e3002463.
    PubMed     Abstract available

    December 2023
  3. SIMMONS HC, Watanabe A, Oguin Iii TH, Van Itallie ES, et al
    A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses.
    PLoS Biol. 2023;21:e3002415.
    PubMed     Abstract available

    November 2023
  4. VALE-COSTA S, Etibor TA, Bras D, Sousa AL, et al
    ATG9A regulates the dissociation of recycling endosomes from microtubules to form liquid influenza A virus inclusions.
    PLoS Biol. 2023;21:e3002290.
    PubMed     Abstract available

  5. ZHU Z, Fan H, Fodor E
    Defining the minimal components of the influenza A virus replication machinery via an in vitro reconstitution system.
    PLoS Biol. 2023;21:e3002370.
    PubMed     Abstract available

    Minding the "T"s beyond the "B"s: Shaping vaccines for future pandemics.
    PLoS Biol. 2023;21:e3002351.
    PubMed     Abstract available

  7. LYTRAS S, Wickenhagen A, Sugrue E, Stewart DG, et al
    Resurrection of 2'-5'-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication.
    PLoS Biol. 2023;21:e3002398.
    PubMed     Abstract available

    August 2023
  8. LADNER JT, Sahl JW
    Towards a post-pandemic future for global pathogen genome sequencing.
    PLoS Biol. 2023;21:e3002225.
    PubMed     Abstract available

  9. LOBINSKA G, Pilpel Y, Nowak MA
    Evolutionary safety of lethal mutagenesis driven by antiviral treatment.
    PLoS Biol. 2023;21:e3002214.
    PubMed     Abstract available

  10. KRAFT TS, Seabright E, Alami S, Jenness SM, et al
    Metapopulation dynamics of SARS-CoV-2 transmission in a small-scale Amazonian society.
    PLoS Biol. 2023;21:e3002108.
    PubMed     Abstract available

    July 2023
  11. OLAJIDE OM, Osman MK, Robert J, Kessler S, et al
    Evolutionarily conserved amino acids in MHC-II mediate bat influenza A virus entry into human cells.
    PLoS Biol. 2023;21:e3002182.
    PubMed     Abstract available

    June 2023
  12. STRINE MS, Cai WL, Wei J, Alfajaro MM, et al
    DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner.
    PLoS Biol. 2023;21:e3002097.
    PubMed     Abstract available

  13. CHEN NFG, Chaguza C, Gagne L, Doucette M, et al
    Development of an amplicon-based sequencing approach in response to the global emergence of mpox.
    PLoS Biol. 2023;21:e3002151.
    PubMed     Abstract available

  14. TSU BV, Agarwal R, Gokhale NS, Kulsuptrakul J, et al
    Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome.
    PLoS Biol. 2023;21:e3002144.
    PubMed     Abstract available

    May 2023
  15. EALES O, Haw D, Wang H, Atchison C, et al
    Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.
    PLoS Biol. 2023;21:e3002118.
    PubMed     Abstract available

    February 2023
  16. SIMS A, Tornaletti LB, Jasim S, Pirillo C, et al
    Superinfection exclusion creates spatially distinct influenza virus populations.
    PLoS Biol. 2023;21:e3001941.
    PubMed     Abstract available

  17. SHILTS J, Crozier TWM, Teixeira-Silva A, Gabaev I, et al
    LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein.
    PLoS Biol. 2023;21:e3001959.
    PubMed     Abstract available

  18. LOO L, Waller MA, Moreno CL, Cole AJ, et al
    Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
    PLoS Biol. 2023;21:e3001967.
    PubMed     Abstract available

    Improve how science advice is provided to governments by learning from "experts in expert advice".
    PLoS Biol. 2023;21:e3002004.
    PubMed     Abstract available

  20. TANG AT, Buchholz DW, Szigety KM, Imbiakha B, et al
    Cell-autonomous requirement for ACE2 across organs in lethal mouse SARS-CoV-2 infection.
    PLoS Biol. 2023;21:e3001989.
    PubMed     Abstract available

    December 2022
  21. BAKER SF, Meistermann H, Tzouros M, Baker A, et al
    Alternative splicing liberates a cryptic cytoplasmic isoform of mitochondrial MECR that antagonizes influenza virus.
    PLoS Biol. 2022;20:e3001934.
    PubMed     Abstract available

    November 2022
  22. MESCI P, de Souza JS, Martin-Sancho L, Macia A, et al
    SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir.
    PLoS Biol. 2022;20:e3001845.
    PubMed     Abstract available

  23. GARCIA G JR, Jeyachandran AV, Wang Y, Irudayam JI, et al
    Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response.
    PLoS Biol. 2022;20:e3001851.
    PubMed     Abstract available

  24. NIEMEYER D, Stenzel S, Veith T, Schroeder S, et al
    SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.
    PLoS Biol. 2022;20:e3001871.
    PubMed     Abstract available

    October 2022
  25. SONG J, Chow RD, Pena-Hernandez MA, Zhang L, et al
    LRRC15 inhibits SARS-CoV-2 cellular entry in trans.
    PLoS Biol. 2022;20:e3001805.
    PubMed     Abstract available

    September 2022
  26. DAY T, Kennedy DA, Read AF, Gandon S, et al
    Pathogen evolution during vaccination campaigns.
    PLoS Biol. 2022;20:e3001804.
    PubMed     Abstract available

  27. CHING KL, de Vries M, Gago J, Dancel-Manning K, et al
    ACE2-containing defensosomes serve as decoys to inhibit SARS-CoV-2 infection.
    PLoS Biol. 2022;20:e3001754.
    PubMed     Abstract available

  28. FERNBACH S, Hale BG
    SARS-CoV-2 takes the bait: Exosomes as endogenous decoys.
    PLoS Biol. 2022;20:e3001787.
    PubMed     Abstract available

    August 2022
  29. LIU H, Riggi M, Rogers J, Meyer M, et al
    A new tool for annotating scientific animations and supporting scientific dialogue.
    PLoS Biol. 2022;20:e3001731.
    PubMed     Abstract available

  30. ZHU Y, Chew KY, Wu M, Karawita AC, et al
    Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells.
    PLoS Biol. 2022;20:e3001728.
    PubMed     Abstract available

    July 2022
  31. BUSNADIEGO I, Abela IA, Frey PM, Hofmaenner DA, et al
    Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
    PLoS Biol. 2022;20:e3001709.
    PubMed     Abstract available

  32. ROELLE SM, Shukla N, Pham AT, Bruchez AM, et al
    Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains.
    PLoS Biol. 2022;20:e3001738.
    PubMed     Abstract available

    June 2022
    Why does viral RNA sometimes persist after recovery from acute infections?
    PLoS Biol. 2022;20:e3001687.
    PubMed     Abstract available

  34. TAUBE JC, Miller PB, Drake JM
    An open-access database of infectious disease transmission trees to explore superspreader epidemiology.
    PLoS Biol. 2022;20:e3001685.
    PubMed     Abstract available

    May 2022
  35. ZHU DY, Gorman MJ, Yuan D, Yu J, et al
    Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.
    PLoS Biol. 2022;20:e3001609.
    PubMed     Abstract available

  36. LU-CULLIGAN A, Tabachnikova A, Perez-Then E, Tokuyama M, et al
    No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.
    PLoS Biol. 2022;20:e3001506.
    PubMed     Abstract available

  37. SYENINA A, Gan ES, Toh JZN, de Alwis R, et al
    Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes.
    PLoS Biol. 2022;20:e3001643.
    PubMed     Abstract available

  38. RICE BL, Lessler J, McKee C, Metcalf CJE, et al
    Why do some coronaviruses become pandemic threats when others do not?
    PLoS Biol. 2022;20:e3001652.
    PubMed     Abstract available

  39. FOLARIN RO, Maina MB, Akinbo AK, Runsewe-Abiodun TI, et al
    Bypassing shortages of personal protective equipment in low-income settings using local production and open source tools.
    PLoS Biol. 2022;20:e3001658.
    PubMed     Abstract available

    March 2022
  40. BESANCON L, Bik E, Heathers J, Meyerowitz-Katz G, et al
    Correction of scientific literature: Too little, too late!
    PLoS Biol. 2022;20:e3001572.
    PubMed     Abstract available

  41. JANG KK, Kaczmarek ME, Dallari S, Chen YH, et al
    Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection.
    PLoS Biol. 2022;20:e3001592.
    PubMed     Abstract available

    February 2022
  42. FINCH E, Lowe R, Fischinger S, de St Aubin M, et al
    SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.
    PLoS Biol. 2022;20:e3001531.
    PubMed     Abstract available

  43. BRIERLEY L, Nanni F, Polka JK, Dey G, et al
    Tracking changes between preprint posting and journal publication during a pandemic.
    PLoS Biol. 2022;20:e3001285.
    PubMed     Abstract available

    December 2021
  44. AMANAT F, Strohmeier S, Meade P, Dambrauskas N, et al
    Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus.
    PLoS Biol. 2021;19:e3001384.
    PubMed     Abstract available

  45. CASTIGLIONE GM, Zhou L, Xu Z, Neiman Z, et al
    Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2.
    PLoS Biol. 2021;19:e3001510.
    PubMed     Abstract available

  46. HERDER V, Dee K, Wojtus JK, Epifano I, et al
    Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    PLoS Biol. 2021;19:e3001065.
    PubMed     Abstract available

    November 2021
  47. MURUATO A, Vu MN, Johnson BA, Davis-Gardner ME, et al
    Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
    PLoS Biol. 2021;19:e3001284.
    PubMed     Abstract available

    October 2021
    Wildlife must be protected from crime and trade for the sake of public and planetary health.
    PLoS Biol. 2021;19:e3001422.
    PubMed     Abstract available

  49. JACK A, Ferro LS, Trnka MJ, Wehri E, et al
    SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA.
    PLoS Biol. 2021;19:e3001425.
    PubMed     Abstract available

    September 2021
  50. MOLLENTZE N, Babayan SA, Streicker DG
    Identifying and prioritizing potential human-infecting viruses from their genome sequences.
    PLoS Biol. 2021;19:e3001390.
    PubMed     Abstract available

    August 2021
  51. WANG SY, Takahashi T, Pine AB, Damsky WE, et al
    Challenges in interpreting cytokine data in COVID-19 affect patient care and management.
    PLoS Biol. 2021;19:e3001373.
    PubMed     Abstract available

    July 2021
  52. KISSLER SM, Fauver JR, Mack C, Olesen SW, et al
    Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.
    PLoS Biol. 2021;19:e3001333.
    PubMed     Abstract available

  53. HOTEZ PJ
    Mounting antiscience aggression in the United States.
    PLoS Biol. 2021;19:e3001369.
    PubMed     Abstract available

    June 2021
  54. HEFFRON AS, McIlwain SJ, Amjadi MF, Baker DA, et al
    The landscape of antibody binding in SARS-CoV-2 infection.
    PLoS Biol. 2021;19:e3001265.
    PubMed     Abstract available

  55. NICHOLS JD, Bogich TL, Howerton E, Bjornstad ON, et al
    Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making.
    PLoS Biol. 2021;19:e3001307.
    PubMed     Abstract available

    May 2021
  56. VOGELS CBF, Breban MI, Ott IM, Alpert T, et al
    Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
    PLoS Biol. 2021;19:e3001236.
    PubMed     Abstract available

  57. FU D, Zhang G, Wang Y, Zhang Z, et al
    Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes.
    PLoS Biol. 2021;19:e3001209.
    PubMed     Abstract available

  58. LOWE-POWER TM, Dyson L, Polter AM
    A generation of junior faculty is at risk from the impacts of COVID-19.
    PLoS Biol. 2021;19:e3001266.
    PubMed     Abstract available

    April 2021
  59. MOGHADAS SM, Vilches TN, Zhang K, Nourbakhsh S, et al
    Evaluation of COVID-19 vaccination strategies with a delayed second dose.
    PLoS Biol. 2021;19:e3001211.
    PubMed     Abstract available

  60. FRASER N, Brierley L, Dey G, Polka JK, et al
    The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape.
    PLoS Biol. 2021;19:e3000959.
    PubMed     Abstract available

  61. GALLAGHER T, McCray PB Jr
    The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
    PLoS Biol. 2021;19:e3001217.
    PubMed     Abstract available

  62. ZHU X, Mannar D, Srivastava SS, Berezuk AM, et al
    Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
    PLoS Biol. 2021;19:e3001237.
    PubMed     Abstract available

  63. FERGUSON J, Dunn S, Best A, Mirza J, et al
    Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key.
    PLoS Biol. 2021;19:e3001216.
    PubMed     Abstract available

    March 2021
    Racism, disease, and vaccine refusal: People of color are dying for access to COVID-19 vaccines.
    PLoS Biol. 2021;19:e3001167.
    PubMed     Abstract available

  65. FULWEILER RW, Davies SW, Biddle JF, Burgin AJ, et al
    Rebuild the Academy: Supporting academic mothers during COVID-19 and beyond.
    PLoS Biol. 2021;19:e3001100.
    PubMed     Abstract available

  66. KIM KS, Ejima K, Iwanami S, Fujita Y, et al
    A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
    PLoS Biol. 2021;19:e3001128.
    PubMed     Abstract available

  67. MACLEAN OA, Lytras S, Weaver S, Singer JB, et al
    Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen.
    PLoS Biol. 2021;19:e3001115.
    PubMed     Abstract available

  68. POHL MO, Busnadiego I, Kufner V, Glas I, et al
    SARS-CoV-2 variants reveal features critical for replication in primary human cells.
    PLoS Biol. 2021;19:e3001006.
    PubMed     Abstract available

  69. RAVINDRA NG, Alfajaro MM, Gasque V, Huston NC, et al
    Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
    PLoS Biol. 2021;19:e3001143.
    PubMed     Abstract available

    February 2021
  70. RIHN SJ, Merits A, Bakshi S, Turnbull ML, et al
    A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.
    PLoS Biol. 2021;19:e3001091.
    PubMed     Abstract available

  71. COMER SP, Cullivan S, Szklanna PB, Weiss L, et al
    COVID-19 induces a hyperactive phenotype in circulating platelets.
    PLoS Biol. 2021;19:e3001109.
    PubMed     Abstract available

    January 2021
  72. HOTEZ PJ
    Anti-science kills: From Soviet embrace of pseudoscience to accelerated attacks on US biomedicine.
    PLoS Biol. 2021;19:e3001068.
    PubMed     Abstract available

    December 2020
  73. KIM JI, Park S, Bae JY, Lee S, et al
    Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus.
    PLoS Biol. 2020;18:e3001024.
    PubMed     Abstract available

  74. REIJNS MAM, Thompson L, Acosta JC, Black HA, et al
    A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection.
    PLoS Biol. 2020;18:e3001030.
    PubMed     Abstract available

    November 2020
  75. KENNEDY DA, Read AF
    Monitor for COVID-19 vaccine resistance evolution during clinical trials.
    PLoS Biol. 2020;18:e3001000.
    PubMed     Abstract available

  76. ALTHOUSE BM, Wenger EA, Miller JC, Scarpino SV, et al
    Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control.
    PLoS Biol. 2020;18:e3000897.
    PubMed     Abstract available

  77. ZHOU Y, Hou Y, Shen J, Mehra R, et al
    A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.
    PLoS Biol. 2020;18:e3000970.
    PubMed     Abstract available

  78. KADING RC, Kingston T
    Common ground: The foundation of interdisciplinary research on bat disease emergence.
    PLoS Biol. 2020;18:e3000947.
    PubMed     Abstract available

    October 2020
  79. KUDO E, Israelow B, Vogels CBF, Lu P, et al
    Detection of SARS-CoV-2 RNA by multiplex RT-qPCR.
    PLoS Biol. 2020;18:e3000867.
    PubMed     Abstract available

  80. BRUCE EA, Huang ML, Perchetti GA, Tighe S, et al
    Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step.
    PLoS Biol. 2020;18:e3000896.
    PubMed     Abstract available

  81. KUCHARSKI AJ, Funk S, Eggo RM
    The COVID-19 response illustrates that traditional academic reward structures and metrics do not reflect crucial contributions to modern science.
    PLoS Biol. 2020;18:e3000913.
    PubMed     Abstract available

    September 2020
  82. SELZER L, Su Z, Pintilie GD, Chiu W, et al
    Full-length three-dimensional structure of the influenza A virus M1 protein and its organization into a matrix layer.
    PLoS Biol. 2020;18:e3000827.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.